Compounds > sulfamethoxazole
Page last updated: 2024-08-16

sulfamethoxazole and griseofulvin

sulfamethoxazole has been researched along with griseofulvin in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's4 (50.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Eichenwald, HF; Schmid, F1
Brazeau, M; Marks, MI; Shapera, RM1
Chen, K; Mitra, S1
Azizighannad, S; Islam, MS; Mitra, S; Renner, F1

Other Studies

8 other study(ies) available for sulfamethoxazole and griseofulvin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
[Antibiotics and chemotherapeutic drugs. 4: Antimycotic agents (griseofulvin, nystatin), sulfonamides, trimethoprim-sulfamethoxazole, nitrofurantoin].
    Fortschritte der Medizin, 1977, Oct-27, Volume: 95, Issue:40

    Topics: Anti-Bacterial Agents; Antifungal Agents; Griseofulvin; Humans; Nitrofurantoin; Nystatin; Sulfamethoxazole; Sulfonamides; Trimethoprim

1977
Pediatric antimicrobial therapy. V.
    Canadian Medical Association journal, 1973, Sep-01, Volume: 109, Issue:5

    Topics: Amphotericin B; Anti-Infective Agents; Antifungal Agents; Bacterial Infections; Child; Drug Therapy, Combination; Griseofulvin; Humans; Iodides; Mycoses; Nystatin; Streptomycin; Sulfamethoxazole; Sulfonamides; Tetracycline; Tolnaftate; Trimethoprim; Vancomycin

1973
Incorporation of functionalized carbon nanotubes into hydrophobic drug crystals for enhancing aqueous dissolution.
    Colloids and surfaces. B, Biointerfaces, 2019, Jan-01, Volume: 173

    Topics: Anti-Bacterial Agents; Antifungal Agents; Chemical Precipitation; Crystallization; Griseofulvin; Humans; Hydrophobic and Hydrophilic Interactions; Nanotubes, Carbon; Solubility; Solvents; Sulfamethoxazole; Technology, Pharmaceutical; Water

2019
Direct incorporation of nano graphene oxide (nGO) into hydrophobic drug crystals for enhanced aqueous dissolution.
    Colloids and surfaces. B, Biointerfaces, 2020, Volume: 189

    Topics: Crystallization; Graphite; Griseofulvin; Hydrophobic and Hydrophilic Interactions; Nanoparticles; Particle Size; Solubility; Sulfamethoxazole; Surface Properties; Water

2020